TradingView
RocketTickers
2022년 2월 8일 오전 12시 58분

NGM Bio’s NGM621 Receives Fast Track Designation from the FDA fo 

설명

NGM: NGM Biopharmaceuticals, Inc.
2022-02-07 08:00:00
NGM Bio’s NGM621 Receives Fast Track Designation from the FDA for the Treatment of Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
더보기